[Public Comment Submission] “Basic Plan for the Promotion of Cancer Control (Draft)” (February 18, 2023)
date : 2/27/2023
Tags: NCDs, Precision Cancer Medicine
On February 18, HGPI has submitted opinions (public comments) on “Basic Plan for the Promotion of Cancer Control (Draft)”to the Health Bureau of the Ministry of Health, Labour and Welfare (MHLW).
Summary of our public comments
- Recommendation 1: Genomic cancer medicine is already widely used in some types of cancer. Therefore, this should be positioned as a technology that everyone should be able to benefit from, rather than an advanced medical treatment as described in the Draft.
- Recommendation 2: As for the measures to be taken in genomic cancer medicine, one should not only focus on gathering scientific evidence, but should also emphasize to enhance medical practice guidelines, and to identify the issues and consider measures to improve access to drugs and clinical trials.
- Recommendation 3: Describe Decentralized Clinical Trials (DCTs) as one of the measures for prompt healthcare implementation, in order to provide patient-oriented and sustainable cancer care.
- Recommendation 4: In order to strengthen human resource development as a foundation to support genome cancer medicine, one should establish and strengthen cooperative relationships among hospitals with respect to specialist personnel, in addition to developing and assigning specialist personnel within the organization respectively.
- Recommendation 5: In cancer education and promotion of cancer knowledge, one should mention genome cancer medicine in addition to cancer in general.
日本語
Top Research & Recommendations Posts
- [Announcement] HGPI Joins Alliance for Transformative Action on Climate and Health (April 22, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Publication Report] Developing and Expanding Cardiovascular Disease Control Plans in Each Prefecture – Challenges and Good Examples for Cardiovascular Disease Control (September 7, 2023)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Public Comment Submission] Opinions Regarding the Proposed “National Action Plan on Antimicrobial Resistance 2023-2027 (Draft)” (March 16, 2023)
Featured Posts
-
2024-04-22
[Registration Open] (Hybrid Format) Intractable Disease Day Symposium: Future Measures for Intractable Diseases from the Perspectives of Patients and Citizens (May, 23 2024)
-
2024-04-23
[Registration Open] (Webinar) The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-30
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Community Development for Senior Health: From Establishing Evidence to Social Implementation” (April 23, 2024)
-
2024-05-02
[Event Report] The 123rd HGPI Seminar – The Current Situation and Future Prospects for Epilepsy in Japan and Around the World (March 6, 2024)
-
2024-05-09
[Registration Open] The Health Policy Academy the 13th Session